Shree Maruti Nandan Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2013.
2013 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Shree Maruti Nandan Pharmaceuticals Private Limited

Shree Maruti Nandan Pharmaceuticals Private Limited, a active private limited company, was established on 08 April 2013 in New Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U24232DL2013PTC250434. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.29 Cr.

It upholds a compliant status. Employing 40 professional, Its leadership includes Gaurav Aggarwal (Director), Brijesh Kumar (Director), Anurag Agarwal (Director). Past directors included Meenu Arora, Bharti Sharma, Anurag Agarwal. It holds ₹20.10 Cr open charges and ₹39.49 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 105 Chaudhary Complex, 9.V S Block, Shakarpur, New Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2013PTC250434

  • Registration Number

    250434

  • Incorporation Date

    08 April 2013

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹1.29 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.29 Cr
  • Company Age 12 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 20.10 Cr
  • Satisfied Charges ₹ 39.49 Cr
  • Revenue Growth **** 9.52%
  • Profit Growth **** 17.65%
  • Ebitda **** 28.19%
  • Net Worth 17.75%
  • Total Assets **** 10.12%
Company report

Shree Maruti Nandan Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Shree Maruti Nandan Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Shree Maruti Nandan Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Gaurav Aggarwal Director 19 Feb 2019 Current
Brijesh Kumar Director 19 Feb 2019 Current
Anurag Agarwal Director 11 Oct 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Dec 2015 Past
Pramod Abcsdd Director 09 Jul 2019 Past
Pramod Abcsdd Additional Director 13 Sep 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Shree Maruti Nandan Pharmaceuticals.

Shree Maruti Nandan Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.52% increase. The company also saw a substantial improvement in profitability, with a 17.65% increase in profit. The company's net worth Soared by an impressive increase of 17.75%.

Shree Maruti Nandan Pharmaceuticals revenue growth over time
Shree Maruti Nandan Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 9.52%
*******
*******
*******
*******
Revenue from Operations
*******
 9.83%
*******
*******
*******
*******
Total Assets
*******
 10.12%
*******
*******
*******
*******
Profit or Loss
*******
 17.65%
*******
*******
*******
*******
Net Worth
*******
 17.75%
*******
*******
*******
*******
EBITDA
*******
 28.19%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Shree Maruti Nandan Pharmaceuticals?

In 2021, Shree Maruti Nandan Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹201,005,815.00

Satisfied Charges

₹394,930,000.00

Charges Breakdown by Lending Institutions
  • Others : 19.94 Cr
  • Hdfc Bank Limited : 0.16 Cr
Latest Charge Details
Date Lender Amount Status
28 Jan 2025 Others ₹5.00 Cr Open
30 Dec 2024 Others ₹14.94 Cr Open
19 Jan 2023 Hdfc Bank Limited ₹1.61 M Open
25 Nov 2023 Others ₹14.71 Cr Satisfied
07 Aug 2023 Axis Bank Limited ₹1.41 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Shree Maruti Nandan Pharmaceuticals?

Shree Maruti Nandan Pharmaceuticals has a workforce of 40 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Shree Maruti Nandan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Maruti Nandan Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Shree Maruti Nandan Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge with Others of Rs. 14.94 Cr registered on 30 Dec 2024 with Charge ID 101032084 was modified on 13 Mar 2025. was completed.

  • Charges

    A charge with Others of Rs. 5.00 Cr registered on 28 Jan 2025 with Charge ID 101059037 was modified on 11 Mar 2025. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 5.00 Cr with Charge ID 101059037 was registered on 28 Jan 2025. was recorded as a recent event.

  • Charges

    A charge registered on 25 Nov 2023 via Charge ID 100821601 with Others was fully satisfied on 21 Jan 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 14.94 Cr with Charge ID 101032084 was registered on 30 Dec 2024. was completed.

  • Annual General Meeting

    Progress on Shree Maruti Nandan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Shree Maruti Nandan Pharmaceuticals Private Limited?

The CIN of Shree Maruti Nandan Pharmaceuticals Private Limited is U24232DL2013PTC250434.

Where is Shree Maruti Nandan Pharmaceuticals Private Limited headquartered?

Shree Maruti Nandan Pharmaceuticals Private Limited is headquartered at 105 Chaudhary Complex, 9.V S Block, Shakarpur, New Delhi, Delhi, 110092.

When was Shree Maruti Nandan Pharmaceuticals Private Limited incorporated?

Shree Maruti Nandan Pharmaceuticals Private Limited was incorporated on 08 April 2013.

Who are the current directors of Shree Maruti Nandan Pharmaceuticals Private Limited?

The current directors of Shree Maruti Nandan Pharmaceuticals Private Limited are

What is the primary industry of Shree Maruti Nandan Pharmaceuticals Private Limited?

The primary industry of Shree Maruti Nandan Pharmaceuticals Private Limited is Trade.

Is Shree Maruti Nandan Pharmaceuticals Private Limited a listed company?

Shree Maruti Nandan Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Shree Maruti Nandan Pharmaceuticals Private Limited?

The authorized capital of Shree Maruti Nandan Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.29 Cr.

What is the compliance status of Shree Maruti Nandan Pharmaceuticals Private Limited?

The compliance status of Shree Maruti Nandan Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available